Presented by Alger
Medicine    September 29, 2015
The Next Healthcare Disruption
Posted by Alan Kotok

The frustration of the physicians come through, piercing the structured format of a scientific journal. In July 2015, 118 oncologists at leading medical centers and cancer research institutes in the U.S. wrote in the journal Mayo Clinic Proceedings that the rising cost of cancer drugs "is causing harm to patients with cancer and their families."

The authors cited prices for cancer drugs approved by Food and Drug Administration in 2014 that exceeded $120,000 for use over one year, with the average price of new cancer drugs increasing 5- to 10-fold over 15 years. They went on to recommend a series of steps to bring down the cost of cancer drugs including more action by FDA on drug prices, negotiations by Medicare for volume discounts, allowing imports from Canada, and new laws and regulations restricting practices that reduce competition.


By clicking on this link you are now leaving The reference to a link to a third party website shall not constitute an endorsement of, or representation or warranty by Alger regarding such websites, the contents of the websites, the views expressed by the creators or contributors to such websites, the products or services of the websites or the operators of the websites. Your access to and use of such linked websites is governed by the terms of use and privacy policies of those sites, and shall be at your own risk. Alger disclaims responsibility for your use of such websites, including the privacy policies and customer information practices of such third-party websites.